SignalCorporate
VIVOS THERAPEUTICS GAAP EPS OF -$0.31 MISSES BY $0.01, REVENUE OF $5.15M MISSES BY $0.99M - SEEKINGALPHA
EPS miss and revenue shortfall signal operational underperformance, pressuring near-term valuation.
What changed
EPS miss and revenue shortfall signal operational underperformance, pressuring near-term valuation.
Why it matters
EPS miss and revenue shortfall signal operational underperformance, pressuring near-term valuation. — impact context not separately stored; see What changed.
← Dashboard
Aug 17, 2026 10:34 AM ET